\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\ appeared\\ thin\\ and\\ pale\\,\\ but\\ otherwise\\ well\\.\\ \\ laboratory\\ workup\\ was\\ significant\\ for\\ a\\ hemoglobin\\ of\\ 10\\.2\\ and\\ a\\ hematocrit\\ of\\ 30\\.2\\.\ \(0\)\
\-\ patient\\ is\\ being\\ treated\\ with\\ chemotherapy\\ \\(chop\\)\\.\\ \\ he\\ will\\ have\\ follow\\ up\\ imaging\\ after\\ his\\ third\\ cycle\\ to\\ assess\\ tumor\\ response\\.\ \(0\)\
\-\ ct\\ angiogram\\ was\\ performed\\ demonstrating\\ a\\ large\\ soft\\ tissue\\ mass\\ present\\ within\\ the\\ mesentery\\ measuring\\ 10\\.3\\ by\\ 7\\.3\\ cm\\ in\\ its\\ greatest\\ dimension\\.\\ \\ the\\ mass\\ appears\\ continuous\\ with\\ multiple\\ loops\\ of\\ small\\ bowel\\,\\ several\\ of\\ which\\ demonstrate\\ diffuse\\ wall\\ thickening\\.\\ \\ the\\ mass\\ is\\ seen\\ to\\ encase\\ the\\ superior\\ mesenteric\\ artery\\,\\ which\\ remains\\ patent\\.\\ \\ there\\ is\\ graying\\ of\\ the\\ surrounding\\ mesenteric\\ fat\\,\\ as\\ well\\ as\\,\\ scattered\\ lymph\\ nodes\\.\\ \\ there\\ is\\ central\\ low\\ attenuation\\ of\\ the\\ mass\\,\\ which\\ may\\ represent\\ necrosis\\.\ \(0\)\
\-\ small\\ bowel\\ lymphoma\ \(5\)\
\-\ small\\ bowel\\ adenocarcinoma\ \(1\)\
\-\ metastastic\\ disease\ \(0\)\
\-\ gist\ \(260\)\
\-\ leiomyosarcoma\ \(24\)\
\-\ small\\ bowel\\ lymphoma\ \(5\)\
\-\ patient\\ had\\ a\\ 2\\-month\\ history\\ of\\ increasing\\ intestinal\\/epigastric\\ pain\\ after\\ large\\ meals\\.\\ \\ the\\ patient\\ also\\ reported\\ a\\ twenty\\-pound\\ weight\\ loss\\ in\\ the\\ past\\ 2\\-months\\.\\ \\ the\\ patient\\ denied\\ night\\ sweats\\,\\ fevers\\,\\ melena\\,\\ hematochezia\\ or\\ shortness\\ of\\ breath\\.\\ \\ past\\ medical\\ history\\ is\\ significant\\ for\\ excision\\ of\\ a\\ melanoma\\ from\\ his\\ chin\\ 2\\-years\\ prior\\,\\ as\\ well\\ as\\,\\ a\\ history\\ of\\ hypertension\\,\\ hyperlipidemia\\,\\ and\\ atherosclerotic\\ disease\\.\ \(0\)\
\-\ the\\ most\\ common\\ location\\ for\\ lymphoma\\ of\\ the\\ gastrointestinal\\ tract\\ is\\ in\\ the\\ stomach\\.\\ however\\,\\ the\\ small\\ bowel\\ is\\ the\\ second\\ most\\ common\\ site\\.\\ non\\-hodgkin\\â\\€\\™s\\ lymphoma\\ is\\ the\\ third\\ most\\ common\\ malignancy\\ of\\ the\\ small\\ bowel\\,\\ representing\\ between\\ 10\\-20\\%\\ of\\ all\\ small\\ bowel\\ malignancies\\.\\ \\ because\\ lymphoma\\ is\\ a\\ soft\\,\\ pliable\\ tumor\\,\\ it\\ tends\\ to\\ cause\\ bowel\\ wall\\ thickening\\ and\\ dilatation\\ of\\ the\\ bowel\\ lumen\\ opposed\\ to\\ obstruction\\.\\ \\ in\\ this\\ case\\,\\ the\\ lymphoma\\ was\\ seen\\ to\\ encase\\ the\\ superior\\ mesenteric\\ artery\\ and\\ other\\ mesenteric\\ vessels\\.\\ \\ the\\ images\\ with\\ oral\\ contrast\\ best\\ demonstrate\\ the\\ dilatation\\ of\\ the\\ small\\ bowel\\ loops\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bowel\\:\\ 0\\.3928100369779922\ \(0\)\
\-\ the\\:\\ 0\\.2809068731594917\ \(0\)\
\-\ small\\:\\ 0\\.25258783914763816\ \(0\)\
\-\ lymphoma\\:\\ 0\\.21872122452709708\ \(0\)\
\-\ mesenteric\\:\\ 0\\.21139746638304183\ \(0\)\
\-\ of\\:\\ 0\\.17967391001338848\ \(0\)\
\-\ encase\\:\\ 0\\.1688872398465544\ \(0\)\
\-\ is\\:\\ 0\\.15086162658726304\ \(0\)\
\-\ loops\\:\\ 0\\.11118441485493417\ \(0\)\
\-\ common\\:\\ 0\\.10413693577148155\ \(0\)\
\-\ dilatation\\:\\ 0\\.09993222154221777\ \(0\)\
\-\ patient\\:\\ 0\\.09954049540891045\ \(0\)\
\-\ as\\:\\ 0\\.09835873811542371\ \(0\)\
\-\ pliable\\:\\ 0\\.09788594658245608\ \(0\)\
\-\ most\\:\\ 0\\.09556449514322311\ \(0\)\
\-\ metastastic\\:\\ 0\\.09353524771191442\ \(0\)\
\-\ mass\\:\\ 0\\.09352027179805468\ \(0\)\
\-\ third\\:\\ 0\\.09321052959568119\ \(0\)\
\-\ well\\:\\ 0\\.08891258117182368\ \(0\)\
\-\ graying\\:\\ 0\\.08805401536930414\ \(0\)\
\-\ which\\:\\ 0\\.08349653798750477\ \(0\)\
\-\ thickening\\:\\ 0\\.0832824958676163\ \(0\)\
\-\ chop\\:\\ 0\\.08174697999691173\ \(0\)\
\-\ gist\\:\\ 0\\.08061644652484314\ \(0\)\
\-\ past\\:\\ 0\\.07968436968242273\ \(0\)\
\-\ chin\\:\\ 0\\.07959375460059702\ \(0\)\
\-\ superior\\:\\ 0\\.0795885646689489\ \(0\)\
\-\ to\\:\\ 0\\.07651020357793273\ \(0\)\
\-\ artery\\:\\ 0\\.0760292876168659\ \(0\)\
\-\ hematochezia\\:\\ 0\\.0749227291459415\ \(0\)\
\-\ wall\\:\\ 0\\.07446785096464745\ \(0\)\
\-\ melena\\:\\ 0\\.07430941115245072\ \(0\)\
\-\ his\\:\\ 0\\.07424313386029138\ \(0\)\
\-\ meals\\:\\ 0\\.07167921195655837\ \(0\)\
\-\ pale\\:\\ 0\\.07078451531169119\ \(0\)\
\-\ tends\\:\\ 0\\.07078451531169119\ \(0\)\
\-\ significant\\:\\ 0\\.07068104510989105\ \(0\)\
\-\ cycle\\:\\ 0\\.07036367142400382\ \(0\)\
\-\ history\\:\\ 0\\.07015573602305927\ \(0\)\
\-\ opposed\\:\\ 0\\.06956848223435518\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.06919194733057257\ \(0\)\
\-\ malignancies\\:\\ 0\\.06882817880984046\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.06717411986566425\ \(0\)\
\-\ mesentery\\:\\ 0\\.06657784737804268\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.06547635355479002\ \(0\)\
\-\ soft\\:\\ 0\\.06517235888706042\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.064718616911675\ \(0\)\
\-\ continuous\\:\\ 0\\.06424164311209736\ \(0\)\
\-\ tumor\\:\\ 0\\.06403134399492345\ \(0\)\
\-\ was\\:\\ 0\\.06399545506551307\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06364135476410866\ \(0\)\
\-\ hematocrit\\:\\ 0\\.06334694646723019\ \(0\)\
\-\ and\\:\\ 0\\.06324008432372036\ \(0\)\
\-\ dimension\\:\\ 0\\.06313446143093882\ \(0\)\
\-\ sweats\\:\\ 0\\.06252114343744805\ \(0\)\
\-\ large\\:\\ 0\\.06133713785462701\ \(0\)\
\-\ greatest\\:\\ 0\\.061213248180377745\ \(0\)\
\-\ in\\:\\ 0\\.060906896411504166\ \(0\)\
\-\ appeared\\:\\ 0\\.060531740210851885\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.060367918041133325\ \(0\)\
\-\ after\\:\\ 0\\.05938663298311498\ \(0\)\
\-\ remains\\:\\ 0\\.05830373999146011\ \(0\)\
\-\ representing\\:\\ 0\\.05790872077012078\ \(0\)\
\-\ workup\\:\\ 0\\.05765322908832855\ \(0\)\
\-\ seen\\:\\ 0\\.05763306780486637\ \(0\)\
\-\ melanoma\\:\\ 0\\.05715980221572682\ \(0\)\
\-\ assess\\:\\ 0\\.056573309595428035\ \(0\)\
\-\ response\\:\\ 0\\.05645976204178741\ \(0\)\
\-\ for\\:\\ 0\\.05565561052896995\ \(0\)\
\-\ patent\\:\\ 0\\.05548853373508181\ \(0\)\
\-\ denied\\:\\ 0\\.055284143866045896\ \(0\)\
\-\ angiogram\\:\\ 0\\.05498467855938686\ \(0\)\
\-\ night\\:\\ 0\\.05498467855938686\ \(0\)\
\-\ lumen\\:\\ 0\\.05450342553993668\ \(0\)\
\-\ fevers\\:\\ 0\\.0540428336423016\ \(0\)\
\-\ scattered\\:\\ 0\\.053260533515690045\ \(0\)\
\-\ nodes\\:\\ 0\\.051996704619067705\ \(0\)\
\-\ disease\\:\\ 0\\.051386428419278714\ \(0\)\
\-\ tract\\:\\ 0\\.05127629025249611\ \(0\)\
\-\ stomach\\:\\ 0\\.0510692714128019\ \(0\)\
\-\ represent\\:\\ 0\\.05093344499550422\ \(0\)\
\-\ demonstrating\\:\\ 0\\.05047115192565978\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.05002795615089583\ \(0\)\
\-\ site\\:\\ 0\\.04936650542317534\ \(0\)\
\-\ best\\:\\ 0\\.049250502739976304\ \(0\)\
\-\ shortness\\:\\ 0\\.04907881677826916\ \(0\)\
\-\ oral\\:\\ 0\\.04902219319732641\ \(0\)\
\-\ there\\:\\ 0\\.04870945881047919\ \(0\)\
\-\ excision\\:\\ 0\\.0482593237420168\ \(0\)\
\-\ increasing\\:\\ 0\\.048206853497177064\ \(0\)\
\-\ thin\\:\\ 0\\.04764600574852603\ \(0\)\
\-\ lymph\\:\\ 0\\.047596443795800095\ \(0\)\
\-\ vessels\\:\\ 0\\.0474980014201088\ \(0\)\
\-\ measuring\\:\\ 0\\.047352010818578996\ \(0\)\
\-\ attenuation\\:\\ 0\\.04683308957039449\ \(0\)\
\-\ hypertension\\:\\ 0\\.04683308957039449\ \(0\)\
\-\ necrosis\\:\\ 0\\.04678713599399847\ \(0\)\
\-\ second\\:\\ 0\\.04582296467122904\ \(0\)\
\-\ malignancy\\:\\ 0\\.04582296467122904\ \(0\)\
\-\ its\\:\\ 0\\.04529145842992631\ \(0\)\
\-\ breath\\:\\ 0\\.04486141333228122\ \(0\)\
\-\ appears\\:\\ 0\\.04482315966007833\ \(0\)\
\-\ laboratory\\:\\ 0\\.044447941580705336\ \(0\)\
\-\ reported\\:\\ 0\\.04408540224190802\ \(0\)\
\-\ otherwise\\:\\ 0\\.04363170256834089\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04346218650425251\ \(0\)\
\-\ obstruction\\:\\ 0\\.042873189307146564\ \(0\)\
\-\ because\\:\\ 0\\.04277809139940653\ \(0\)\
\-\ weight\\:\\ 0\\.042683828915997396\ \(0\)\
\-\ being\\:\\ 0\\.04265259121216489\ \(0\)\
\-\ location\\:\\ 0\\.04262144418394273\ \(0\)\
\-\ cause\\:\\ 0\\.04169817190650602\ \(0\)\
\-\ central\\:\\ 0\\.04087448298247167\ \(0\)\
\-\ surrounding\\:\\ 0\\.040821754897555795\ \(0\)\
\-\ several\\:\\ 0\\.04015887495133909\ \(0\)\
\-\ between\\:\\ 0\\.039770411037224826\ \(0\)\
\-\ will\\:\\ 0\\.039395520725933476\ \(0\)\
\-\ medical\\:\\ 0\\.03890054164699472\ \(0\)\
\-\ diffuse\\:\\ 0\\.03838539582676802\ \(0\)\
\-\ treated\\:\\ 0\\.03811635209304862\ \(0\)\
\-\ fat\\:\\ 0\\.038075553018464395\ \(0\)\
\-\ loss\\:\\ 0\\.037290549063266475\ \(0\)\
\-\ all\\:\\ 0\\.03643604737054895\ \(0\)\
\-\ he\\:\\ 0\\.0362455151964653\ \(0\)\
\-\ however\\:\\ 0\\.03622836068651548\ \(0\)\
\-\ performed\\:\\ 0\\.03621123355807761\ \(0\)\
\-\ with\\:\\ 0\\.035956253026361504\ \(0\)\
\-\ cm\\:\\ 0\\.03515281846197381\ \(0\)\
\-\ low\\:\\ 0\\.03512185121482862\ \(0\)\
\-\ prior\\:\\ 0\\.03424634373278617\ \(0\)\
\-\ follow\\:\\ 0\\.03299677416542268\ \(0\)\
\-\ imaging\\:\\ 0\\.032167213753587554\ \(0\)\
\-\ tissue\\:\\ 0\\.03210867490851592\ \(0\)\
\-\ other\\:\\ 0\\.03178663141899685\ \(0\)\
\-\ present\\:\\ 0\\.031408143129381505\ \(0\)\
\-\ it\\:\\ 0\\.03133184925202608\ \(0\)\
\-\ may\\:\\ 0\\.03080211959143214\ \(0\)\
\-\ case\\:\\ 0\\.03075055705257415\ \(0\)\
\-\ have\\:\\ 0\\.030577074963971943\ \(0\)\
\-\ had\\:\\ 0\\.030496396811802128\ \(0\)\
\-\ up\\:\\ 0\\.030277609657312902\ \(0\)\
\-\ but\\:\\ 0\\.0302677700017053\ \(0\)\
\-\ multiple\\:\\ 0\\.02993847982407289\ \(0\)\
\-\ contrast\\:\\ 0\\.029740030294934033\ \(0\)\
\-\ also\\:\\ 0\\.028790791842054464\ \(0\)\
\-\ images\\:\\ 0\\.028313072815981524\ \(0\)\
\-\ within\\:\\ 0\\.02819081387440361\ \(0\)\
\-\ by\\:\\ 0\\.025992740095625983\ \(0\)\
\-\ from\\:\\ 0\\.024309478336854266\ \(0\)\
\-\ ct\\:\\ 0\\.023302705367184193\ \(0\)\
\-\ pain\\:\\ 0\\.0219027053069228\ \(0\)\
\-\ or\\:\\ 0\\.021293397270479\ \(0\)\
\-\ this\\:\\ 0\\.02103239228401027\ \(0\)\
